AstraZeneca PLC
AZN
$171.34
-$1.96-1.13%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.97B | 7.68B | 5.72B | 8.18B | 7.11B |
| Total Receivables | 15.99B | 15.17B | 14.30B | 15.15B | 15.17B |
| Inventory | 6.93B | 6.57B | 6.56B | 6.59B | 6.47B |
| Prepaid Expenses | -- | -- | 2.03B | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 76.00M | 203.00M | 112.00M | 12.00M | 195.00M |
| Total Current Assets | 27.97B | 29.61B | 28.72B | 29.94B | 28.94B |
|
|
|||||
| Total Current Assets | 27.97B | 29.61B | 28.72B | 29.94B | 28.94B |
| Net Property, Plant & Equipment | 16.30B | 14.94B | 14.70B | 13.78B | 13.23B |
| Long-term Investments | 21.18B | 21.19B | 21.24B | 21.22B | 21.22B |
| Goodwill | 21.18B | 21.19B | 21.24B | 21.22B | 21.22B |
| Total Other Intangibles | 37.72B | 36.91B | 37.85B | 38.19B | 37.93B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.75B | 8.69B | 9.04B | 9.04B | 8.97B |
| Total Assets | 115.83B | 114.02B | 114.07B | 114.46B | 112.42B |
|
|
|||||
| Total Accounts Payable | 22.89B | 22.51B | 3.82B | 25.03B | 23.99B |
| Total Accrued Expenses | -- | -- | 19.30B | -- | -- |
| Short-term Debt | 2.95B | 3.01B | 644.00M | 1.71B | 2.03B |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.39B | 5.05B | 2.92B | 4.87B | 4.92B |
| Total Finance Division Other Current Liabilities | 2.32B | 2.00B | 3.93B | 2.44B | 2.60B |
| Total Other Current Liabilities | 2.32B | 2.00B | 3.93B | 2.44B | 2.60B |
| Total Current Liabilities | 31.55B | 32.57B | 30.62B | 34.05B | 33.54B |
|
|
|||||
| Total Current Liabilities | 31.55B | 32.57B | 30.62B | 34.05B | 33.54B |
| Long-Term Debt | 23.69B | 24.46B | 24.72B | 24.70B | 24.71B |
| Short-term Debt | 2.95B | 3.01B | 644.00M | 1.71B | 2.03B |
| Capital Leases | 2.32B | 1.51B | 1.42B | 1.38B | 1.27B |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.90B | 8.09B | 8.60B | 8.35B | 8.09B |
| Total Liabilities | 65.46B | 66.63B | 65.36B | 68.49B | 67.61B |
|
|
|||||
| Common Stock & APIC | 35.67B | 35.66B | 35.65B | 35.63B | 35.63B |
| Retained Earnings | 12.59B | 9.67B | 12.60B | 8.21B | 7.02B |
| Treasury Stock & Other | 2.03B | 2.00B | 414.00M | 2.04B | 2.07B |
| Total Common Equity | 50.30B | 47.33B | 48.67B | 45.89B | 44.72B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 50.30B | 47.33B | 48.67B | 45.89B | 44.72B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 75.00M | 51.00M | 52.00M | 83.00M | 91.00M |
| Total Equity | 50.37B | 47.38B | 48.72B | 45.97B | 44.81B |
|
|
|||||